Telomir Pharmaceuticals, Inc. Common Stock
TELO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,102 | -$5,070 | -$2,180 | -$2,898 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $1,376 | $0 |
| Change in WC | $77 | -$291 | -$30 | $101 |
| Other Non-Cash | $98 | $4,664 | -$29 | $2,192 |
| Operating Cash Flow | -$927 | -$696 | -$863 | -$606 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $7,502 | $1,048 | $0 | $1,037 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $7,502 | $1,048 | $0 | $1,037 |
| Forex Effect | $0 | -$0 | $0 | $0 |
| Net Chg. in Cash | $6,575 | $351 | -$863 | $431 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $754 | $403 | $1,266 | $835 |
| End Cash | $7,329 | $754 | $403 | $1,266 |
| Free Cash Flow | -$927 | -$696 | -$863 | -$606 |